Sort
51,593 grants matching “hepatitis”
Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis
$426,530Jessica L Maiers · Indiana University Indianapolis · R01 · FY2023 · DK
Sympathetic circadian dysfunction in obesity-related hepatocarcinogenesis
$426,448Loning None Fu · Baylor College Of Medicine · R01 · FY2022 · CA
RNAi for the Treatment of Viral Hepatitis
$426,443Mark A Kay · Stanford University · R01 · FY2013 · AI
Prevention of the Complications of Bleeding Disorders Through Hemo Tmt Centers
$426,434Patricia Dominic · Hemophilia Of Georgia, Inc. · U01 · FY2006 · DD
CROSSTALK BETWEEN GUT MICROBIOTA AND HEPATOCELLULAR CARCINOMA INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
$426,425Prasun Kumar Jalal · Baylor College Of Medicine · R21 · FY2024 · CA
Antibody responses to HCV vaccine antigens in infection and vaccination
$426,357Mansun Law · Scripps Research Institute, The · U19 · FY2019 · AI
METABOLISM OF GENETIC VARIANTS OF APOLIPOPROTEIN B
$426,331Washington University · R37 · FY2003 · HL
Modeling distinct neonatal purine metabolism to inform vaccine development
$426,300Ofer Levy · Boston Children'S Hospital · R01 · FY2013 · AI
Role of PDZK1 in lipid metabolism and atherosclerosis
$426,300Olivier N. Kocher · Beth Israel Deaconess Medical Center · R01 · FY2014 · HL
Structure and Function of Nucleic Acids
$426,275Ignacio Tinoco · University Of California Berkeley · R01 · FY2012 · GM
HCV Disease Management in HIV- HCV Coinfected IDUs
$426,264Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2010 · DA
Qualitative Exploration of Low-Frequency Heroin Injectors Not in Drug Treatment
$426,231Alexander H Kral · Research Triangle Institute · R01 · FY2008 · DA
Hormonal regulation of LDL receptor trafficking
$426,075Alan R. Saltiel · University Of California, San Diego · R01 · FY2024 · DK
TET1 in non-alcoholic fatty liver disease development
$426,069Chiung-Kuei Huang · Tulane University Of Louisiana · R01 · FY2024 · DK
Phase I Clinical Trials of Novel Anticancer Agents
$426,064University Of Pittsburgh At Pittsburgh · U01 · FY2005 · CA
Molecular Regulation of Apoprotein B Degradation
$426,053Edward A Fisher · New York University School Of Medicine · R01 · FY2016 · HL
Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk
$426,049John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2022 · DK
Serum markers of glucagon sensitivity in calorie restricted humans
$425,958Jennifer Helene Stern · University Of Arizona · R21 · FY2025 · AG
Molecular Regulation of Apoprotein B Degradation
$425,945Edward A Fisher · New York University School Of Medicine · R01 · FY2009 · HL
Translational Research on Alcohol, Immunodeficiency, and Aging In COMpAAAS
$425,927Amy Caroline Justice · Yale University · U24 · FY2014 · AA
Endogenous Aldosterone and Glucose Homeostasis
$425,891James Matthew Luther · Vanderbilt University · R01 · FY2013 · DK
Identification of vascular inductive signals in liver regeneration
$425,888Shahin Rafii · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · DK
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and
$425,838Chunqi Li · Phylonix Pharmaceuticals, Inc. · R44 · FY2009 · ES
Texas National HIV Behavioral Surveillance
$425,758Sharon K Melville · Texas State Dept Of Health Services · U1B · FY2012 · PS
A Multi-Center Study of Acute Liver Failure in Adults
$425,660William M Lee · Ut Southwestern Medical Center · U01 · FY2010 · DK